These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Interstitial lung fibrosis in rheumatoid arthritis--comparison of lung function and bronchoalveolar lavage]. Petermann W; Hoppe-Seyler S; Entzian P; Barth J Pneumologie; 1990 Feb; 44 Suppl 1():540-1. PubMed ID: 2367460 [TBL] [Abstract][Full Text] [Related]
3. [Results of cytostatic therapy of malignant hemoblastoses]. Stacher A Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311 [No Abstract] [Full Text] [Related]
5. [Bronchoalveolar lavage in fibrosing alveolitis--a parameter for evaluating activity and prognosis?]. de Wall N; Endres P Pneumologie; 1991 Oct; 45(10):785-9. PubMed ID: 1758846 [TBL] [Abstract][Full Text] [Related]
6. [Diagnostic bronchoalveolar lavage in assessing the efficacy of the treatment of idiopathic fibrosing alveolitis]. Gerasin VA; Zhuravlev AV; Novikova LN; Palamarchuk GF Ter Arkh; 1988; 60(12):63-6. PubMed ID: 3247657 [TBL] [Abstract][Full Text] [Related]
7. [Mast cells in bronchoalveolar lavage fluid of patients with interstitial lung diseases]. Schildge J; Klar B; Hardung-Backes M Pneumologie; 2003 Apr; 57(4):202-7. PubMed ID: 12690558 [TBL] [Abstract][Full Text] [Related]
8. [Secondary tumors in hemoblastoses during cytostatic treatment]. Hartwich G; Butzler W Med Klin; 1971 Oct; 66(43):1445-50. PubMed ID: 5001553 [No Abstract] [Full Text] [Related]
9. [Bronchoalveolar lavage in diseases of rheumatic origin]. Petermann W Z Rheumatol; 1990; 49(5):291-3. PubMed ID: 2080686 [TBL] [Abstract][Full Text] [Related]
10. Induced sputum and bronchoalveolar lavage as tools for evaluating the effects of inhaled corticosteroids in patients with asthma. Nocker RE; Out TA; Weller FR; de Riemer MJ; Jansen HM; van der Zee JS J Lab Clin Med; 2000 Jul; 136(1):39-49. PubMed ID: 10882226 [TBL] [Abstract][Full Text] [Related]
11. Different expression of endothelin in the bronchoalveolar lavage in patients with pulmonary diseases. Reichenberger F; Schauer J; Kellner K; Sack U; Stiehl P; Winkler J Lung; 2001; 179(3):163-74. PubMed ID: 11891606 [TBL] [Abstract][Full Text] [Related]
12. [Clinical report on the cytostatic agent cytostasan]. Hesse P; Jaschke E; Anger G Dtsch Gesundheitsw; 1972 Oct; 27(43):2058-64. PubMed ID: 5087017 [No Abstract] [Full Text] [Related]
13. Bronchoalveolar lavage in other interstitial lung diseases. Costabel U; Guzman J; Bonella F; Oshimo S Semin Respir Crit Care Med; 2007 Oct; 28(5):514-24. PubMed ID: 17975779 [TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage (BAL) in newly diagnosed patients with collagen vascular diseases. Chhajed PN; Doshi KP; Athavale AU; Bichile LS; Shah AC Indian J Chest Dis Allied Sci; 1998; 40(4):243-50. PubMed ID: 10091464 [TBL] [Abstract][Full Text] [Related]
15. [Results obtained with the clinical use of adriamycin]. Esposito S; Taylor LA Haematologica; 1971; 56(9):343-66. PubMed ID: 5004536 [No Abstract] [Full Text] [Related]
17. Production of type 2 cytokines by CD8+ lung cells is associated with greater decline in pulmonary function in patients with systemic sclerosis. Atamas SP; Yurovsky VV; Wise R; Wigley FM; Goter Robinson CJ; Henry P; Alms WJ; White B Arthritis Rheum; 1999 Jun; 42(6):1168-78. PubMed ID: 10366109 [TBL] [Abstract][Full Text] [Related]